Episode 211: semaglutide for AUD, preventing post-vax syncope, PCR panel for RTI, fluvoxamine for long-COVID

Join primary care professors Mark Ebell, Kate Rowland, Gary Ferenchick and Henry Barry as they discuss 4 new studies: semaglutide for alcohol use disorder, a vibrating cool pack to prevent post vaccination syncope, PCR for 23 respiratory pathogens in primary care to reduce antibiotic use, and fluvoxamine for Long-COVID Fatigue.

Links

Semaglutide for AUD: https://pubmed.ncbi.nlm.nih.gov/42070571/

Vibrating cool pack for vaccine syncope: https://pubmed.ncbi.nlm.nih.gov/41692229/

Point of care PCR for acute RTI: https://pubmed.ncbi.nlm.nih.gov/42149561/

Likelihood that pathogen is commensal vs pathogenic: https://pubmed.ncbi.nlm.nih.gov/39864052/

Fluvoxamine and long COVID: Ann Intern Med. 2026;179(5):621-628  https://pubmed.ncbi.nlm.nih.gov/41911553/